.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Moodys
Boehringer Ingelheim
US Army
Covington
QuintilesIMS
McKesson
Dow
Cipla
Deloitte

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017441

« Back to Dashboard

NDA 017441 describes INFED, which is a drug marketed by Allergan Sales Llc and is included in one NDA. It is available from two suppliers. Additional details are available on the INFED profile page.

The generic ingredient in INFED is iron dextran. There are seventy-seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the iron dextran profile page.

Summary for 017441

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 017441

Ingredient-typeIron
Mechanism of ActionPhosphate Chelating Activity

Suppliers and Packaging for NDA: 017441

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
INFED iron dextran INJECTABLE;INJECTION 017441 NDA Actavis Pharma, Inc. 52544-931 52544-931-02 10 VIAL, SINGLE-DOSE in 1 CARTON (52544-931-02) > 2 mL in 1 VIAL, SINGLE-DOSE
INFED iron dextran INJECTABLE;INJECTION 017441 NDA General Injectables & Vaccines, Inc 52584-931 52584-931-07 1 VIAL, SINGLE-DOSE in 1 BAG (52584-931-07) > 2 mL in 1 VIAL, SINGLE-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 50MG IRON/ML
Approval Date:Approved Prior to Jan 1, 1982TE:BPRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Cerilliant
McKinsey
Johnson and Johnson
Fish and Richardson
Harvard Business School
US Department of Justice
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot